Mentioned:
AIFF -8.77% NVDA -6.20%
One of the most exciting early stage publicly traded neuroscience companies in North America is fully funded to take their technology to the next level.
What’s happening:
- Firefly Neuroscience (NASDAQ: AIFF) has successfully raised $8.8M USD through warrant conversions
By the numbers:
- $5.6M USD came in through the exercise of 823,530 warrants priced at $6.83 USD
- $3.2M USD came in through the exercise of 800,000 warrants priced at $4.00 USD
Why it matters:
- Firefly Neuroscience just recently became one of the first ever publicly traded medical technology companies to be accepted into Nvidia’s (NASDAQ: NVDA) Connect Program
Going deeper:
- Firefly Neuroscience has publicly stated the new infusion of capital will be focused around using their Brain Network Analytics technology platform to build out one of the first ever foundational artificial intelligence models for the human brain
- Neuroscience has continued to come into focus in both Silicon Valley and Wall Street of late, fuelled in large part by Tether just recently announcing they are investing heavily in building out their own open source technology for brain interface technology in collaboration with Blackrock Neurotech
